AAAAAA

   
Results: 1-7 |
Results: 7
DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH G-CSF FOR PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER PATIENTS
Authors: DEGRAAF H WILLEMSE PHB BONG SB PIERSMA H TJABBES T VANVEELEN H COENEN JLLM DEVRIES EGE
Citation: H. Degraaf et al., DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH G-CSF FOR PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 21-21
MITOXANTRONE AND METHOTREXATE (MM) IN ELDERLY PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC)
Authors: VANVEELEN H TJABBES T BONG SB PIERSMA H RUNHAAR EA VERMEER RJ SCHOLTENS T
Citation: H. Vanveelen et al., MITOXANTRONE AND METHOTREXATE (MM) IN ELDERLY PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 93-93
LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE
Authors: DOMBERNOWSKY P SMITH I FALKSON G LEONARD R PANASCI L BELLMUNT J BEZWODA W GARDIN G GUDGEON A MORGAN M FORNASIERO A HOFFMANN W MICHEL J HATSCHEK T TJABBES T CHAUDRI HA HORNBERGER U TRUNET PF
Citation: P. Dombernowsky et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE, Journal of clinical oncology, 16(2), 1998, pp. 453-461
AUTOIMMUNE HYPERTHYROIDISM OCCURRING LATE AFTER RADIOIODINE TREATMENTFOR VOLUME REDUCTION OF LARGE MULTINODULAR GOITERS
Authors: HUYSMANS DAKC HERMUS ARMM EDELBROEK MAL TJABBES T OOSTDIJK A ROSS HA CORSTENS FHM KLOPPENBORG PWC
Citation: Dakc. Huysmans et al., AUTOIMMUNE HYPERTHYROIDISM OCCURRING LATE AFTER RADIOIODINE TREATMENTFOR VOLUME REDUCTION OF LARGE MULTINODULAR GOITERS, Thyroid, 7(4), 1997, pp. 535-539
A CASE OF TIZANIDINE-INDUCED HEPATIC-INJURY
Authors: DEGRAAF EM OOSTERVELD M TJABBES T STRICKER BHC
Citation: Em. Degraaf et al., A CASE OF TIZANIDINE-INDUCED HEPATIC-INJURY, Journal of hepatology, 25(5), 1996, pp. 772-773
DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR PREMENOPAUSAL PATIENTS WITH NODE-POSITIVE BREAST-CANCER
Authors: DEGRAAF H WILLEMSE PHB BONG SB PIERSMA H TJABBES T VANVEELEN H COENEN JLLM DEVRIES EGE
Citation: H. Degraaf et al., DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR PREMENOPAUSAL PATIENTS WITH NODE-POSITIVE BREAST-CANCER, Oncology, 53(4), 1996, pp. 289-294
EVALUATION OF A CYTOLOGICAL SCORING SYSTEM FOR PREDICTING HISTOLOGICAL GRADE AND DISEASE-FREE SURVIVAL IN PRIMARY BREAST-CANCER
Authors: DEGRAAF H WILLEMSE P LADDE BE VANDENBERGEN HA KREBBER M TJABBES T SLUITER WJ
Citation: H. Degraaf et al., EVALUATION OF A CYTOLOGICAL SCORING SYSTEM FOR PREDICTING HISTOLOGICAL GRADE AND DISEASE-FREE SURVIVAL IN PRIMARY BREAST-CANCER, Cytopathology, 5(5), 1994, pp. 294-300
Risultati: 1-7 |